News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Immunotherapy could offer hope for some men with aggressive prostate cancers
A group of men with especially aggressive prostate cancer may respond unusually well to immunotherapy, a major new study reports.
Artificial intelligence can predict how cancers will evolve and spread
Scientists have used artificial intelligence to predict how cancers will progress and evolve – so that doctors can design the most effective treatment for each patient.
Genetic ‘weather forecasting’ could predict bowel cancer’s response to treatment
Blood tests could predict how long it takes until bowel cancer returns based on the same principle used in forecasting the weather, a new study has found.
ICR responds to NICE decision about CAR T immunotherapy for non-Hodgkin lymphoma
The ICR responds to draft decision not to recommend CAR T cell therapy for two types of non-Hodgkin lymphoma.
ICR statement on allegations of bullying
The Institute of Cancer Research, London, is making the following statement regarding an investigation we have conducted into allegations of bullying by a staff member.
New computer prediction tool can forecast how cancer will resist drugs before they are given to patients
Sophisticated new computer software can be used to predict how cancers may respond to a new drug before it has ever been given to patients.
Drug combination gives ‘exciting’ results in ovarian and lung cancer in early trial
Combining a new targeted cancer drug with chemotherapy has shown promise in an early clinical trial, in patients with ovarian or lung cancer for whom all other treatments had failed.
Breast cancer vulnerability could point way to new target treatments
Researchers have identified a vulnerability in some breast cancer cells of a certain type – called triple negative breast cancer – that could be exploited by future targeted drugs.
Tumour 'diaries' track cancers' evolutionary history and predict the future
Scientists have developed a complex mathematical model that uses a snapshot of tumours’ genetic code to reach back in time, revealing its evolutionary history.
Discovery Club members hear about how philanthropy is making a difference to people with cancer
Members of the ICR’s Discovery Club, our high-level giving club of visionary supporters, learned about the difference that philanthropy is making to people with cancer at an event in the impressive surroundings of Two Temple Place, in Central London.
New prostate cancer blood test detects early treatment failure
A new prostate cancer blood test can detect early signs that cancer is evolving to become resistant to treatment, a new study has found.
Increased risk of myeloid blood cancers in relatives of patients
The largest ever study of its type is the first to definitively show an increased risk of blood cancers in relatives of patients.
